Home Newsfeeds Morgan Stanley Maintains Overweight on Axonics, Raises Price Target to $80

Morgan Stanley Maintains Overweight on Axonics, Raises Price Target to $80

Morgan Stanley analyst Cecilia Furlong maintains Axonics (NASDAQ:AXNX) with a Overweight and raises the price target from $73 to $80.

byBenzinga Newsdesk

August 2, 2022

1 minute read

Morgan Stanley analyst Cecilia Furlong maintains Axonics (NASDAQ:AXNX) with a Overweight and raises the price target from $73 to $80.

Shopify Q4 Earnings Highlights: Revenue And EPS Beats, GMV Up 13%, Q1 Guidance And More

By Chris Katje

February 15, 6:05 PM

Global commerce company Shopify Inc (NYSE: SHOP) reported fourth-quarter financial results after market close Wednesday. Here are the key highlights.

SHOP

Stratasys Comments On Press Release Issued By 3D Systems; Stratasys Still Waiting For Critical Due Diligence And Regulatory Analysis From 3D Systems

By Happy Mohamed

July 28, 11:03 AM

Stratasys Ltd. (NASDAQ:SSYS) ("Stratasys" or the "Company"), a leader in polymer 3D printing solutions, today issued the following statement in response to a press release issued by 3D Systems

DDD

Needham Maintains Buy on Axcelis Technologies, Raises Price Target to $87

By Benzinga Newsdesk

August 5, 9:42 AM

Needham analyst Quinn Bolton maintains Axcelis Technologies (NASDAQ:ACLS) with a Buy and raises the price target from $76 to $87.

ACLS

Morgan Stanley Maintains Overweight on Axonics, Raises Price Target to $80

Related Posts

Shopify Q4 Earnings Highlights: Revenue And EPS Beats, GMV Up 13%, Q1 Guidance And More

Stratasys Comments On Press Release Issued By 3D Systems; Stratasys Still Waiting For Critical Due Diligence And Regulatory Analysis From 3D Systems

Needham Maintains Buy on Axcelis Technologies, Raises Price Target to $87

Top Financial Media Stories Tuesday, September 20: Apple Feels The Forex Pinch, Pepsi Ends Russian Production, Beyond Meat’s COO Arrested And More..